Dach Leslie A
Known title: DirectorCIK: 0001371248
Dach Leslie A's purchase track record
Dach Leslie A has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/7/2021 | RUN | $18K | -30.3% | -34.9% | -11.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| RUN | ▲ Buy | Grant | 9,687 | $0 | 1/2/2026 | View on chart |
| RUN | ▲ Buy | Grant | 17,357 | $0 | 1/2/2025 | View on chart |
| RUN | ▲ Buy | Grant | 11,920 | $0 | 1/2/2024 | View on chart |
| RUN | ▲ Buy | Grant | 5,839 | $0 | 1/3/2023 | View on chart |
| RUN | ▲ Buy | Option Exercise | 25,000 | $80K | 1/21/2022 | View on chart |
| RUN | ▲ Buy | Grant | 4,162 | $0 | 1/3/2022 | View on chart |
| RUN | ▲ Buy | Open Market | 14 | $601 | 12/7/2021 | View on chart |
| RUN | ▲ Buy | Open Market | 423 | $18K | 12/7/2021 | View on chart |
| RUN | ▼ Sell | Open Market | 13,013 | $561K | 9/22/2021 | View on chart |
| RUN | ▼ Sell | Open Market | 10,000 | $446K | 8/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Sunrun analysts lower price targets amid valuation debate
Citigroup, Barclays and Goldman Sachs all kept their coverage of Sunrun but reduced their price targets to $14, $12 and $11 respectively. A separate valuation estimate says the stock may be as much as 52% below its intrinsic value ahead of the upcoming Q3 earnings release. Yahoo reported unusual options activity that could reflect multimillion‑dollar positions. The mix of lower targets and potential undervaluation adds mixed signals for the stock.
Sunrun analysts lower price targets amid valuation debate. Citigroup, Barclays and Goldman Sachs all kept their coverage of Sunrun but reduced their price targets to $14, $12 and $11 respectively. A separate valuation estimate says the stock may be as much as 52% below its intrinsic value ahead of the upcoming Q3 earnings release. Yahoo reported unusual options activity that could reflect multimillion‑dollar positions. The mix of lower targets and potential undervaluation adds mixed signals for the stock.